HUM vs RXST · P/E 39, rev $117.76B vs rev $139.9M
Humana Inc (HUM) versus Rxsight Inc (RXST) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Rxsight Inc (RXST) is a medical devices company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported RXST revenue for 2024-12-31 was $139.9M. Net income was -$27.5M. Revenue was up 57.1% from 2023-12-31 to 2024-12-31. RXST currently screens at market cap $198.3M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. RXST currently screens at market cap $198.3M.
Not investment advice. Open the HUM and RXST stock pages for the full models.
Not investment advice.